These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29664556)

  • 1. Clinical problems in hemodialysis patients with autosomal dominant polycystic kidney disease.
    Kocyigit I; Eroglu E; Gungor O
    Semin Dial; 2018 May; 31(3):268-277. PubMed ID: 29664556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.
    Lee VW; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):595-602.e12. PubMed ID: 26718164
    [No Abstract]   [Full Text] [Related]  

  • 3. The patient with ADPKD on maintenance hemodialysis.
    Ritz E; Jones E; Waldherr R; Zeier M
    Contrib Nephrol; 1995; 115():33-8. PubMed ID: 8585916
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications of autosomal dominant polycystic kidney disease in hemodialysis patients.
    Norby SM; Torres VE
    Semin Dial; 2000; 13(1):30-5. PubMed ID: 10740669
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
    Christophe JL; van Ypersele de Strihou C; Pirson Y
    Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
    Perrone RD; Ruthazer R; Terrin NC
    Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?
    Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
    Nephrology (Carlton); 2018 Jan; 23(1):31-36. PubMed ID: 27653449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant polycystic kidney disease in children.
    Cadnapaphornchai MA
    Curr Opin Pediatr; 2015 Apr; 27(2):193-200. PubMed ID: 25635587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
    Gronwald W; Klein MS; Zeltner R; Schulze BD; Reinhold SW; Deutschmann M; Immervoll AK; Böger CA; Banas B; Eckardt KU; Oefner PJ
    Kidney Int; 2011 Jun; 79(11):1244-53. PubMed ID: 21389975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease.
    Murphy EL; Droher ML; DiMaio MS; Dahl NK
    Am J Kidney Dis; 2018 Dec; 72(6):866-872. PubMed ID: 29606500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease.
    Jankowska M; Chmielewski M; Lichodziejewska-Niemierko M; Jagodziński P; Rutkowski B
    Int Urol Nephrol; 2015 Oct; 47(10):1739-44. PubMed ID: 26282281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
    McCarthy S; McMullen M
    ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016.
    Chebib FT; Torres VE
    Am J Kidney Dis; 2016 May; 67(5):792-810. PubMed ID: 26530876
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease.
    Fourtounas C; Panteris V; Valis D
    Am J Kidney Dis; 2002 Mar; 39(3):660. PubMed ID: 11877589
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the clinical management of autosomal dominant polycystic kidney disease.
    Torra R
    F1000Res; 2019; 8():. PubMed ID: 30755792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment.
    Watanabe K; Fujii T; Makabe S; Nakajima H; Sato M; Kataoka H; Tsuchiya K; Nitta K; Mochizuki T
    Intern Med; 2019 Jan; 58(1):85-89. PubMed ID: 30146585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; Cadnapaphornchai MA; Chonchol MB; Schrier RW; Gitomer B
    Am J Nephrol; 2016; 44(3):171-8. PubMed ID: 27548646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis.
    Boonpheng B; Thongprayoon C; Wijarnpreecha K; Medaura J; Chebib FT; Cheungpasitporn W
    Nephrology (Carlton); 2019 Jun; 24(6):638-646. PubMed ID: 29952039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.